Armen H. Jr. Tashjian
#94,017
Most Influential Person Now
Armen H. Jr. Tashjian's AcademicInfluence.com Rankings
Armen H. Jr. Tashjianphilosophy Degrees
Philosophy
#3526
World Rank
#5680
Historical Rank
Logic
#1210
World Rank
#1901
Historical Rank

Armen H. Jr. Tashjianbiology Degrees
Biology
#4421
World Rank
#6590
Historical Rank
Endocrinology
#30
World Rank
#34
Historical Rank
Biochemistry
#454
World Rank
#535
Historical Rank

Download Badge
Philosophy Biology
Armen H. Jr. Tashjian's Degrees
- Doctorate Medicine Harvard University
Why Is Armen H. Jr. Tashjian Influential?
(Suggest an Edit or Addition)Armen H. Jr. Tashjian's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Establishment of clonal strains of rat pituitary tumor cells that secrete growth hormone. (1968) (626)
- C-cell hyperplasia preceding medullary thyroid carcinoma. (1973) (423)
- Thyrotropin releasing hormone: direct evidence for stimulation of prolactin production by pituitary cells in culture. (1971) (401)
- Prostaglandin-stimulated bone resorption by rheumatoid synovia. A possible mechanism for bone destruction in rheumatoid arthritis. (1975) (378)
- Alpha and beta human transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvaria. (1985) (374)
- EVIDENCE THAT THE BONE RESORPTION-STIMULATING FACTOR PRODUCED BY MOUSE FIBROSARCOMA CELLS IS PROSTAGLANDIN E2 (1972) (362)
- The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a. An 18-year experience. (1988) (311)
- PRODUCTION OF BOTH PROLACTIN AND GROWTH HORMONE BY CLONAL STRAINS OF RAT PITUITARY TUMOR CELLS (1970) (303)
- Early diagnosis of medullary carcinoma of the thyroid gland by means of calcitonin assay. (1971) (264)
- Epidermal growth factor stimulates prostaglandin production and bone resorption in cultured mouse calvaria. (1978) (256)
- Thyrotropin-releasing hormone regulates the number of its own receptors in the GH3 strain of pituitary cells in culture. (1975) (249)
- Enhanced expression of vascular endothelial growth factor in human SaOS-2 osteoblast-like cells and murine osteoblasts induced by insulin-like growth factor I. (1996) (238)
- [46] Clonal strains of hormone-producing pituitary cells (1979) (232)
- Tumor necrosis factor-alpha (cachectin) stimulates bone resorption in mouse calvaria via a prostaglandin-mediated mechanism. (1987) (227)
- Epidermal growth factor and thyrotropin-releasing hormone act similarly on a clonal pituitary cell strain. Modulation of hormone production and inhibition of cell proliferation (1980) (203)
- Pathogenesis of hypocalcemia in primary hypomagnesemia: normal end-organ responsiveness to parathyroid hormone, impaired parathyroid gland function. (1973) (200)
- Establishment of Four Functional, Clonal Strains of Animal Cells in Culture (1966) (191)
- Hypercalcemia and tumor-prostaglandins: the VX2 carcinoma model in the rabbit. (1975) (188)
- Natural history of familial medullary thyroid carcinoma: effect of a program for early diagnosis. (1978) (185)
- Relationship of thyrotropin-releasing hormone-induced spike and plateau phases in cytosolic free Ca2+ concentrations to hormone secretion. Selective blockade using ionomycin and nifedipine. (1984) (182)
- Platelet-derived growth factor stimulates bone resorption via a prostaglandin-mediated mechanism. (1982) (176)
- Hydrocortisone inhibits prostaglandin production by mouse fibrosarcoma cells (1975) (168)
- Studies in familial (medullary) thyroid carcinoma. (1972) (167)
- Characterization of beta-adrenergic receptors on rat and human osteoblast-like cells and demonstration that beta-receptor agonists can stimulate bone resorption in organ culture. (1993) (165)
- Receptors for thyrotropin-releasing hormone in prolactin producing rat pituitary cells in culture. (1973) (161)
- The syndrome of excessive thyrocalcitonin produced by medullary carcinoma of the thyroid. (1968) (156)
- Medullary carcinoma of the thyroid gland. Studies of thyrocalcitonin in plasma and tumor extracts. (1968) (155)
- Prostaglandin production by mouse fibrosarcoma cells in culture: inhibition by indomethacin and aspirin. (1972) (154)
- Inositol tetrakis- and pentakisphosphates in GH4 cells. (1985) (150)
- Distribution of calcitonin-containing cells in the normal adult human thyroid gland: a correlation of morphology with peptide content. (1974) (149)
- Teriparatide [Human PTH(1‐34)]: 2.5 Years of Experience on the Use and Safety of the Drug for the Treatment of Osteoporosis (2005) (145)
- Thyrotropin-releasing hormone-induced spike and plateau in cytosolic free Ca2+ concentrations in pituitary cells. Relation to prolactin release. (1984) (143)
- Direct modulation by estradiol of the response of human bone cells (SaOS-2) to human parathyroid hormone (PTH) and PTH-related protein. (1989) (143)
- Distinct patterns of cytoplasmic protein phosphorylation related to regulation of synthesis and release of prolactin by GH cells. (1983) (140)
- IMMUNOCHEMICAL IDENTIFICATION OF PARATHYROID HORMONE IN NON-PARATHYROID NEOPLASMS ASSOCIATED WITH HYPERCALCEMIA (1964) (139)
- A possible role of cyclic AMP in mediating the effects of thyrotropin-releasing hormone on prolactin release and on prolactin and growth hormone synthesis in pituitary cells in culture. (1976) (139)
- Calcitonin and carcinoembryonic antigen as tumor markers in medullary thyroid carcinoma. (1978) (136)
- Commentary on Clinical Safety of Recombinant Human Parathyroid Hormone 1‐34 in the Treatment of Osteoporosis in Men and Postmenopausal Women (2002) (136)
- CONTROL OF GROWTH HORMONE PRODUCTION BY A CLONAL STRAIN OF RAT PITUITARY CELLS (1969) (134)
- Calcitonin binding sites in bone: relationships to biological response and "escape". (1978) (128)
- Novel mechanism of intracellular calcium release in pituitary cells. (1991) (128)
- Characterization of phorbol ester receptors and their down-modulation in GH4C1 rat pituitary cells. (1981) (127)
- Vasoactive intestinal peptide stimulates bone resorption via a cyclic adenosine 3',5'-monophosphate-dependent mechanism. (1983) (126)
- Biological activities of prostaglandin analogues and metabolites on bone in organ culture (1977) (125)
- Clinical characteristics distinguishing hereditary from sporadic medullary thyroid carcinoma. Treatment implications. (1980) (123)
- NOVEL HYPOTHALAMIC ARACHIDONATE PRODUCTS STIMULATE SOMATOSTATIN RELEASE FROM THE MEDIAN EMINENCE1 (1983) (119)
- ESTABLISHMENT OF A CLONAL STRAIN OF HEPATOMA CELLS WHICH SECRETE ALBUMIN (1969) (119)
- Detection of medullary thyroid cancer by calcitonin assay in families. (1972) (116)
- Crystal structure of human parathyroid hormone 1-34 at 0.9-A resolution. (2000) (109)
- Human osteopetrosis: a histological, ultrastructural, and biochemical study. (1980) (104)
- Effects of parathyroid hormone and calcitonin on osteoclast formation in vitro. (1980) (103)
- The clinical and screening age-at-onset distribution for the MEN-2 syndrome. (1989) (101)
- Prostaglandins, calcium metabolism and cancer. (1974) (101)
- Three activators of protein kinase C, bryostatins, dioleins, and phorbol esters, show differing specificities of action on GH4 pituitary cells. (1986) (100)
- Overexpression of protein kinase C epsilon is oncogenic in rat colonic epithelial cells. (1996) (100)
- Receptor-binding affinities and biological activities of analogs of thyrotropin-releasing hormone in prolactin-producing pituitary cells in culture. (1974) (99)
- Role of calcium in the thyrotropin-releasing hormone-stimulated release of prolactin from pituitary cells in culture. (1978) (99)
- Thyrotropin-releasing hormone is not the sole physiologic mediator of prolactin release during suckling. (1974) (97)
- Successful treatment of hypercalcemia by indomethacin in mice bearing a prostaglandin-producing fibrosarcoma. (1973) (93)
- RENAL ADENOCARCINOMA CONTAINING A PARATHYROID HORMONE-LIKE SUBSTANCE AND ASSOCIATED WITH MARKED HYPERCALCEMIA. (1964) (92)
- Thyrotropin-releasing hormone induces redistribution of protein kinase C in GH4C1 rat pituitary cells. (1985) (91)
- Human milk lipids. II. The influence of dietary carbohydrates and fat on the fatty acids of mature milk. A study in four ethnic groups. (1965) (90)
- Tumor-promoting phorbol esters affect production of prolactin and growth hormone by rat pituitary cells. (1981) (87)
- Stimulation of prostaglandin production in bone by phorbol diesters and melittin. (1978) (86)
- Actions of growth factors on plasma calcium. Epidermal growth factor and human transforming growth factor-alpha cause elevation of plasma calcium in mice. (1986) (86)
- Clonal strains of hormone-producing pituitary cells. (1979) (85)
- Age-resolving Osteopetrosis: A Rat Model Implicating Microphthalmia and the Related Transcription Factor TFE3 (1998) (84)
- Pseudohypoparathyroidism: assays of parathyroid hormone and thyrocalcitonin. (1966) (84)
- Functional receptors for vasoactive intestinal peptide on human osteosarcoma cells. (1984) (82)
- PKCδ acts as a growth and tumor suppressor in rat colonic epithelial cells (1999) (81)
- Demonstration by immunoperoxidase staining of hyperplasia of parafollicular cells in the thyroid gland in hyperparathyroidism. (1973) (80)
- Voltage-dependent calcium channels in pituitary cells in culture. II. Participation in thyrotropin-releasing hormone action on prolactin release. (1984) (80)
- Human calcitonin. Immunologic assay, cytologic localization and studies on medullary thyroid carcinoma. (1974) (80)
- Subunits of human chorionic gonadotropin: unbalanced synthesis and secretion by clonal cell strains derived from a bronchogenic carcinoma. (1973) (77)
- Dual actions of phorbol esters on cytosolic free Ca2+ concentrations and reconstitution with ionomycin of acute thyrotropin-releasing hormone responses. (1985) (77)
- Establishment of a calcitonin-producing rat medullary thyroid carcinoma cell line. II. Secretory studies of the tumor and cells in culture. (1980) (76)
- Management of occult medullary thyroid carcinoma: evidenced only by serum calcitonin level elevations after apparently adequate neck operations. (1978) (76)
- Intravenous infusion of prostaglandin E2 raises plasma calcium concentration in the rat. (1975) (76)
- Protein kinase Cε is oncogenic in colon epithelial cells by interaction with the ras signal transduction pathway (1998) (75)
- Receptor-mediated release of plasma membrane-associated calcium and stimulation of calcium uptake by thyrotropin-releasing hormone in pituitary cells in culture. (1981) (75)
- Calmodulin is a selective mediator of Ca(2+)-induced Ca2+ release via the ryanodine receptor-like Ca2+ channel triggered by cyclic ADP-ribose. (1995) (75)
- Measurement of cytosolic free Ca2+ concentrations in human and rat osteosarcoma cells: actions of bone resorption-stimulating hormones. (1986) (74)
- ALKYLATION AND OXIDATION OF METHIONINE IN BOVINE PARATHYROID HORMONE: EFFECTS ON HORMONAL ACTIVITY AND ANTIGENICITY. (1964) (74)
- Voltage-dependent calcium channels in pituitary cells in culture. I. Characterization by 45Ca2+ fluxes. (1984) (72)
- Age-related probability of development of hereditary medullary thyroid carcinoma. (1982) (71)
- C-cell hyperplasia and medullary thyroid carcinoma in the rat. An immunohistochemical and ultrastructural analysis. (1979) (71)
- Role of prostaglandins in the production of hypercalcemia by tumors. (1978) (69)
- Dual actions of 1,25-dihydroxycholecalciferol on intracellular Ca2+ in GH4C1 cells: evidence for effects on voltage-operated Ca2+ channels and Na+/Ca2+ exchange. (1989) (69)
- Bone resorption in organ culture: inhibition by the divalent cation ionophores A23187 and X-537A. (1976) (68)
- Human parathyroid hormone (PTH)-related protein and human PTH: comparative biological activities on human bone cells and bone resorption. (1988) (66)
- Cyclooxygenase products of arachidonic acid metabolism by mouse bone in organ culture. (1980) (66)
- Inositol 1-,4-,5-trisphosphate-dependent Ca2+ signaling by the recombinant human PTH/PTHrP receptor stably expressed in a human kidney cell line. (1996) (61)
- Production of prolactin by smooth muscle cells cultured from human uterine fibroid tumors. (1993) (61)
- Cushing's syndrome caused by ACTH- and calcitonin-secreting medullary carcinoma of the thyroid. (1970) (61)
- Functional identification and quantitation of three intracellular calcium pools in GH4C1 cells: evidence that the caffeine-responsive pool is coupled to a thapsigargin-resistant, ATP-dependent process. (1993) (61)
- Concentrations of calcitonin and catecholamines in pheochromocytomas, a mucosal neuroma and medullary thyroid carcinoma. (1973) (61)
- Production of a low molecular weight eosinophil polymorphonuclear leukocyte chemotactic factor by anaplastic squamous cell carcinomas of human lung. (1978) (61)
- Unusual sensitivity of cytosolic free Ca2+ to changes in extracellular Ca2+ in rat C-cells. (1986) (60)
- Characterization of an early inhibitory effect of glucocorticoids on stimulated adrenocorticotropin and endorphin release from a clonal strain of mouse pituitary cells. (1982) (58)
- Signaling by N- and C-terminal sequences of parathyroid hormone-related protein in hippocampal neurons. (1995) (57)
- Epidermal growth factor and phorbol ester actions on human osteosarcoma cells. Characterization of response and nonresponsive cell lines. (1982) (57)
- Modulation of somatostatin receptors by thyrotropin-releasing hormone in a clonal pituitary cell strain. (1980) (56)
- Prostaglandins, Hypercalcemia and Cancer (1975) (56)
- Growth in suspension culture of rat pituitary cells which produce growth hormone and prolactin. (1971) (56)
- Regulation of prolactin mRNA by 1,25-dihydroxyvitamin D3 in GH4C1 cells. (1983) (55)
- Serum histaminase and calcitonin levels in medullary carcinoma of the thyroid. (1972) (55)
- Thyrotropin-releasing Hormone-induced Spike and Plateau in Cytosolic Free Ca2+ Concentrations in Pituitary Cells (1984) (54)
- Effects of cations and colchicine on the release of prolactin and growth hormone by functional pituitary tumor cells in culture. (1973) (53)
- Hydrocortisone increases the number of receptors for thyrotropin-releasing hormone on pituitary cells in culture. (1977) (53)
- Stimulation by parathyroid hormone of 45Ca2+ uptake in osteoblast-like cells: possible involvement of alkaline phosphatase. (1990) (51)
- Agonist-independent, muscle-type-specific signal transduction pathways in cat esophageal and lower esophageal sphincter circular smooth muscle. (1995) (51)
- Natural history of the familial medullary thyroid carcinoma-pheochromocytoma syndrome and the identification of preneoplastic stages by screening studies: a five-year report. (1975) (51)
- Modulation of peptide binding to specific receptors on rat pituitary cells by tumor-promoting phorbol esters: decreased binding of thyrotropin-releasing hormone and somatostatin as well as epidermal growth factor. (1982) (50)
- The clinical course after definitive operation for medullary thyroid carcinoma. (1983) (50)
- Transfer of Bilirubin Uridine Diphosphate-Glucuronyltransferase to Enzyme-Deficient Rats (1970) (50)
- Immunoassay of thyrocalcitonin. I. The method and its serological specificity. (1969) (50)
- Plasma concentrations of 13,14-dihydro-15-keto-prostaglandin E2 in rabbits bearing the VX2 carcinoma: effects of hydrocortisone and indomethacin. (1977) (49)
- Hypercalcemia in dogs with adenocarcinoma derived from apocrine glands of the anal sac. Biochemical and histomorphometric investigations. (1983) (48)
- Establishment of a clonal strain of hepatoma cells which maintain in culture the five enzymes of the urea cycle (1974) (48)
- Mechanism of spontaneous intracellular calcium fluctuations in single GH4C1 rat pituitary cells. (1993) (48)
- Hypercalcemia and calcinosis in Florida horses: implication of the shrub, Cestrum diurnum, as the causative agent. (1975) (48)
- The two-mutational-event theory in medullary thyroid cancer. (1979) (48)
- Parathyroid hormone stimulates bone resorption via a Na–Ca exchange mechanism (1980) (48)
- Molecular cloning of a complementary deoxyribonucleic acid encoding the thyrotropin-releasing hormone receptor and regulation of its messenger ribonucleic acid in rat GH cells. (1992) (47)
- Complement biosynthesis in vitro by rat hepatoma cell strains. (1975) (47)
- Molecular cloning of a complementary deoxyribonucleic acid encoding the thyrotropin-releasing hormone receptor and regulation of its messenger ribonucleic acid in rat GH cells. (1992) (46)
- Comparison of Recombinant Human PTH(1–34) (LY333334) with a C‐Terminally Substituted Analog of Human PTH‐Related Protein(1–34) (RS‐66271): In Vitro Activity and In Vivo Pharmacological Effects in Rats (1999) (46)
- Characterization of neurotensin production by a line of rat medullary thyroid carcinoma cells. (1980) (46)
- Vitamin D stimulates prolactin synthesis by GH4C1 cells incubated in chemically defined medium. (1982) (45)
- Thyrotropin-releasing hormone (TRH) elevation of inositol trisphosphate and cytosolic free calcium is dependent on receptor number. Evidence for multiple rapid interactions between TRH and its receptor. (1986) (45)
- Diacylglycerol increases cytosolic free Ca2+ concentration in rat pituitary cells. Relationship to thyrotropin-releasing hormone action. (1987) (45)
- Surgical approach to early familial medullary carcinoma of the thyroid gland. (1972) (44)
- Studies on the role of the liver in the metabolism of parathyroid hormone. I. Effects of partial hepatectomy and incubation of the hormone with tissue homogenates. (1972) (44)
- Structure‐activity studies of the s‐echistatin inhibition of bone resorption (1994) (44)
- Erratum: Teriparatide human PTH(1-34): 2.5 Years of experience on the use and safety of the drug for the treatment of osteoporosis (Journal of Bone and Mineral Research (March 2006) 21 (354-365)) (2006) (43)
- Evidence for parathyroid hormone in nonparathyroid tumors associated with hypercalcemia. (1965) (42)
- Modulation of recombinant human prostate-specific antigen: activation by Hofmeister salts and inhibition by azapeptides. Appendix: thermodynamic interpretation of the activation by concentrated salts. (2001) (41)
- CHAPTER 6 – Cell Culture Studies of Thyrotropin-Releasing Hormone Action (1977) (41)
- Effects of Ca ++ and Mg ++ on secretion and synthesis of growth hormone and prolactin by clonal strains of pituitary cell in culture. (1973) (41)
- Mechanisms of desensitization to parathyroid hormone in human osteoblast-like SaOS-2 cells. (1992) (41)
- Serum prolactin and TSH: effects of nursing and pyroGlu-His-ProNH2 administration in postpartum women. (1973) (40)
- Hypercalcemia in dogs with lymphosarcoma. Biochemical, ultrastructural, and histomorphometric investigations. (1983) (40)
- Neplanocin A. Actions on S-adenosylhomocysteine hydrolase and on hormone synthesis by GH4C1 cells. (1986) (40)
- Thimerosal potentiates Ca2+ release mediated by both the inositol 1,4,5-trisphosphate and the ryanodine receptors in sea urchin eggs. Implications for mechanistic studies on Ca2+ signaling. (1994) (39)
- Familial pseudohypoparathyroidism. Role of parathyroid hormone and thyrocalcitonin. (1968) (38)
- Effects of hydrocortisone on the hypercalcemia and plasma levels of 13,14-dihydro-15-keto-prostaglandin E2 in mice bearing the HSDM1 fibrosarcoma. (1977) (38)
- Total thyroidectomy for occult familial medullary carcinoma of the thyroid in children. (1976) (38)
- Evidence for increased synthesis as well as increased degradation of protein kinase C after treatment of human osteosarcoma cells with phorbol ester. (1987) (38)
- Ionomycin acts as an ionophore to release TRH-regulated Ca2+ stores from GH4C1 cells. (1986) (37)
- Characterization and regulation of receptors for epidermal growth factor in mouse calvaria. (1980) (37)
- Immunocytochemical localization of calcitonin‐producing cells in a strumal carcinoid with amyloid stroma (1979) (36)
- The mechanism of inactivation of S-adenosylhomocysteinase by 2'-deoxyadenosine. (1980) (36)
- Thyrotropin-releasing hormone and epidermal growth factor stimulate prolactin synthesis by a pathway(s) that differs from that used by phorbol esters: dissociation of actions by calcium dependency and additivity. (1985) (36)
- The syndrome of multiple mucosal neuromas and medullary thyroid carcinoma in childhood (1975) (35)
- Distribution of calcitonin-containing cells in the normal neonatal human thyroid gland: a correlation of morphology with peptide content. (1975) (35)
- Relationship between biological responsiveness to phorbol esters and receptor levels in GH4C1 rat pituitary cells. (1981) (35)
- Induction of prolactin synthesis in rat pituitary tumor cells by 5-bromodeoxyuridine (1977) (35)
- C-cell granule heterogeneity in man. An ultrastructural immunocytochemical study. (1978) (34)
- Dietary menhaden oil lowers plasma prostaglandins and calcium in mice bearing the prostaglandin-producing HSDM1 fibrosarcoma. (1984) (34)
- Homeostasis of plasma calcium: effects of actinomycin D, parathyroidectomy and thyrocalcitonin. (1965) (34)
- Subsecond and second changes in inositol polyphosphates in GH4C1 cells induced by thyrotropin-releasing hormone. (1987) (34)
- Human milk lipids. 3. Short-term effects of dietary carbohydrate and fat. (1965) (33)
- Acute phase reactants ceruloplasmin and haptoglobin and their relationship to plasma prostaglandins in rabbits bearing the VS2 carcinoma (1978) (33)
- Animal cell cultures as a source of hormones (1969) (32)
- Two squamous cell carcinomas not associated with humoral hypercalcemia produce a potent bone resorption-stimulating factor which is interleukin-1 alpha. (1989) (32)
- Loss of growth hormone production following hybridization of a functional rat pituitary cell strain with a mouse fibroblast line. (1971) (31)
- Systemic effects of the VX2 carcinoma on the osseous skeleton. A quantitative study of trabecular bone. (1978) (31)
- Protein kinase Cepsilon is oncogenic in colon epithelial cells by interaction with the ras signal transduction pathway. (1998) (30)
- Chromosomal analysis, organ-specific function and appearance of six clonal strains of rat pituitary tumor cells. (1970) (29)
- Hyperparathyroidism due to clear cell hyperplasia. Serial determinations of serum ionized calcium, parathyroid hormone and calcitonin. (1973) (29)
- Immunochemical relatedness of porcine, bovine, ovine and primate pituitary growth hormones. (1965) (29)
- PKCdelta acts as a growth and tumor suppressor in rat colonic epithelial cells. (1999) (29)
- Direct modulation by androgens of the response of human bone cells (SaOS-2) to human parathyroid hormone (PTH) and PTH-related protein. (1989) (29)
- Ionomycin inhibits thyrotropin-releasing hormone-induced translocation of protein kinase C in GH4C1 pituitary cells. (1987) (28)
- STUDIES OF GROWTH HORMONE BY MICRO‐COMPLEMENT FIXATION * (1968) (27)
- Functional receptors for epidermal growth factor on human osteosarcoma cells (1981) (26)
- Thyrotropin-releasing hormone activates Na+/H+ exchange in rat pituitary cells. (1987) (26)
- Cellular immune responses in familial medullary thyroid carcinoma. (1977) (25)
- Beta-adrenergic receptor kinase-1 acutely regulates PTH/PTHrP receptor signalling in human osteoblastlike cells. (1997) (25)
- IMMUNOASSAY OF PARATHYROID HORMONE BY QUANTITATIVE COMPLEMENT FIXATION. (1964) (25)
- Management of parathyroid glands in surgery for medullary thyroid carcinoma. (1975) (25)
- 2-Thiophenecarboxylic acid: a hypoglycemic, antilipolytic agent with hypocalcemic and hypophosphatemic effects in rats. (1969) (24)
- Time-dependent changes in protein kinase C distribution and disappearance in phorbol ester-treated human osteosarcoma cells. (1987) (24)
- Association of phorbol ester receptor down modulation with a cryptic receptor state. (1983) (24)
- METABOLISM OF BILIRUBIN BY A CLONAL STRAIN OF RAT HEPATOMA CELLS (1970) (24)
- Medullary thyroid carcinoma detected by serum calcitonin assay. (1972) (23)
- Antibodies to porcine thyrocalcitonin: effects on the hypocalcemic activity of calf, rat and monkey thyroid extracts. (1965) (23)
- Short chain fatty acids increase prolactin and growth hormone production and alter cell morphology in the GH3 strain of rat pituitary cells. (1981) (23)
- Medullary thyroid carcinoma: ectopic production of peptides with ACTH-like, corticotrophin releasing factor-like and prolactin production-stimulating activities. (1976) (23)
- Platelet-derived growth factor increases prostaglandin production and decreases epidermal growth factor receptors in human osteosarcoma cells. (1982) (22)
- Plasma calcitonin in pycnodysostosis: intermittently high basal levels and exaggerated responses to calcium and glucagon infusions. (1973) (22)
- Adenylyl cyclase and cyclic nucleotide phosphodiesterases in GH-Strains of rat pituitary cells. (1977) (22)
- Tumor Humors and the Hypercalcemias of Cancer (1974) (21)
- Evidence for multiple intracellular calcium pools in GH4C1 cells: investigations using thapsigargin. (1991) (21)
- Synthesis of the ninth component of complement by a clonal strain of rat hepatoma cells. (1970) (21)
- Modulation by 1,25-dihydroxycholecalciferol of the acute change in cytosolic free calcium induced by thyrotropin-releasing hormone in GH4C1 pituitary cells. (1988) (21)
- Transient neonatal hypocalcemia, hypomagnesemia, and high serum parathyroid hormone with maternal hyperparathyroidism. (1975) (21)
- Identification of aromatase activity in rodent pituitary cell strains. (1983) (21)
- Inhibition by ouabain of parathyroid hormone-stimulated bone resorption. (1981) (20)
- Identification of distinct signalling pathways for somatostatin receptors SSTR1 and SSTR2 as revealed by microphysiometry. (1999) (20)
- Immunochemical studies with antisera to fractions of human growth hormone which are high or low in pigeon crop gland-stimulating activity. (1965) (20)
- DL-threo-beta-Fluoroaspartate and DL-threo-beta-fluoroasparagine: selective cytotoxic agents for mammalian cells in culture. (1982) (20)
- Role of the osteoclast in prostaglandin E2-stimulated bone resorption: a correlative morphometric and biochemical analysis. (1980) (20)
- Localization of residual medullary thyroid cancer by thallium/technetium scintigraphy. (1985) (20)
- Squamous cell carcinomas often produce more than a single bone resorption-stimulating factor: role of interleukin-1 alpha*. (1990) (19)
- Insulin-like growth factor-I inhibits parathyroid hormone-stimulated and enhances prostaglandin E2-stimulated adenosine 3',5'-monophosphate production by human osteoblast-like SaOS-2 cells. (1993) (19)
- p21Waf1/Cip1 and p53 are downstream effectors of protein kinase C delta in tumor suppression and differentiation in human colon cancer cells (2005) (19)
- Unexpected resistance to x-irradiation in a strain of hybrid mammalian cells. (1972) (19)
- Medullary carcinoma of the thyroid gland: the complete syndrome in a child. (1973) (19)
- Relationship between mezerein-mediated biological responses and phorbol ester receptor occupancy. (1983) (19)
- Production of an antibody to bovine parathyroid hormone. (1962) (19)
- Influence of exogenous gonadotropins, antibody formation, and hysterectomy on the duration of luteal function in hypophysectomized rats. (1970) (18)
- Extended RNA synthesis in isolated nuclei from rat pituitary tumor cells. (1976) (18)
- Serum albumin production by hepatoma cells in culture: direct evidence for stimulation by hydrocortisone. (1969) (18)
- Mechanism of parathyroid hormone action: effects of actinomycin D on hormone-stimulated ion movements in vivo and in vitro. (1964) (18)
- Measurement of thyrocalcitonin-like activity in urine of patients with medullary carcinoma. (1971) (18)
- pH homeostasis in pituitary GH4C1 cells: basal intracellular pH is regulated by cytosolic free Ca2+ concentration. (1992) (17)
- Acute phase reactants ceruloplasmin and haptoglobin and their relationship to plasma prostaglandins in rabbits bearing the VX2 carcinoma (1978) (17)
- Clonal strains of rat medullary thyroid carcinoma cells that produce neurotensin and calcitonin. Functional and morphologic studies. (1983) (17)
- Platelet-derived growth factor selectively decreases prolactin production in pituitary cells in culture. (1983) (17)
- Importance of transients in cytosolic free calcium concentrations on activation of Na+/H+ exchange in GH4C1 pituitary cells. (1991) (17)
- Degradation of thyrotropin-releasing hormone by the GH3 strain of pituitary cells in culture. (1975) (17)
- Evidence that the thyrotropin-releasing hormone receptor and its ligand are recycled dissociated from each other. (1995) (16)
- Inhibition of capacitative Ca2+ entry into cells by farnesylcysteine analogs. (1996) (16)
- Subcellular localization of thyrocalcitonin. (1966) (16)
- Establishment of a calcitonin-producing rat medullary thyroid carcinoma cell line. I. Morphological studies of the tumor and cells in culture. (1980) (16)
- Action of cholera toxin on hormone synthesis and release in GH cells: evidence that adenosine 3',5'-monophosphate does not mediate the decrease in growth hormone synthesis caused by thyrotropin-releasing hormone. (1980) (16)
- Intrinsic tryptophan fluorescence of membranes of GH3 pituitary cells: quenching by thyrotropin-releasing hormone. (1975) (16)
- Analysis by high performance liquid chromatography of cyclooxygenase products of arachidonic acid metabolism in plasma of rabbits bearing the VX2 carcinoma. (1980) (16)
- Palytoxin: an extraordinarily potent stimulator of prostaglandin production and bone resorption in cultured mouse calvariae. (1987) (16)
- Structural basis for the binding specificity of a SSTR1-selective analog of somatostatin. (1999) (15)
- Actions of palytoxin on Na+ and Ca2+ homeostasis in human osteoblast-like Saos-2 cells. (1995) (15)
- Inhibition of stimulated bone resorption by vanadate. (1983) (15)
- Hormonal control of tyrosine aminotransferase, prolactin, and growth hormone induction in somatic cell hybrids. (1980) (15)
- Importance of extracellular domains for ligand binding in the thyrotropin-releasing hormone receptor. (1995) (14)
- Possible linear order of genes for endocrine neoplasia type 2, the P red cell antigen and HL-A on chromosome 6. (1976) (14)
- Immunocytochemical analysis of prolactin production by monolayer cultures of GH3 rat anterior pituitary tumor cells: II. Variation in prolactin content of individual cell colonies, and dynamics of stimulation with thyrotropin‐releasing hormone (TRH) (1980) (14)
- Regulation of neurotensin release by a continuous line of mammalian C-cells: the role of biogenic amines. (1983) (14)
- Thyrotropin-releasing hormone modulation of uridine uptake in rat pituitary cells. Evidence that uridine phosphorylation is regulated. (1978) (13)
- Rapid, quantitative estimation of human placental lactogen in maternal serum by complement fixation. (1970) (13)
- Mechanisms of activation of Na+/H+ exchange in human osteoblast-like SaOS-2 cells. (1992) (13)
- ASSAY OF HUMAN PARATHYROID HORMONE. (1964) (13)
- Prostaglandin-induced bone resorption by rheumatoid synovia. (1975) (13)
- Intracellular site of prolactin synthesis in rat pituitary cells in culture. (1974) (13)
- Use of GH4C1 cell variants to demonstrate a non-spare receptor model for thyrotropin-releasing hormone action (1985) (13)
- Regulation of endogenous thyrotropin-releasing hormone (TRH) receptor messenger RNA by TRH in GH4C1 cells. (1993) (13)
- Thyrocalcitonin: Ultracentrifugation in Gradients of Sucrose (1966) (13)
- Identification of Asn289 as a ligand binding site in the rat thyrotropin-releasing hormone (THR) receptor as determined by complementary modifications in the ligand and receptor: a new model for THR binding. (1995) (13)
- Incorporation of beta-fluoroasparagine into peptides prevents N-linked glycosylation. In vitro studies with synthetic fluoropeptides. (1986) (13)
- MEN-2 tumor associations suggest a linear order of specific endocrine tumor genes. (1989) (12)
- Transcriptional regulation by dexamethasone of endogenous thyrotropin-releasing hormone receptor messenger ribonucleic acid in rat pituitary GH4C1 cells. (1993) (12)
- Protein phosphatase inhibitors and bone resorption: inhibition by okadaic acid and biphasic actions of calyculin-A. (1992) (12)
- Role of protein kinase A in the regulation of cytosolic free calcium in human osteoblast-like SaOS-2 cells. (1993) (12)
- proTRH gene expression by fetal pancreatic islets in culture. (1990) (11)
- Comparison of the inhibitory effects of propargylamine and pargyline on brain and liver monoamine oxidase activity. (1975) (11)
- Involvement of alkaline phosphatase in the modulation of receptor signaling in osteoblasts: Evidence for a difference between human parathyroid hormone‐related protein and human parathyroid hormone (1994) (11)
- Effects of parathyroidectomy and cautery of the thyroid gland on the plasma calcium level of rats with autotransplanted parathyroid glands. (1966) (11)
- Regulation of endogenous thyrotropin-releasing hormone receptor messenger RNA in GH4C1 cells: roles of protein and RNA synthesis. (1993) (11)
- p21(Waf1/Cip1) and p53 are downstream effectors of protein kinase C delta in tumor suppression and differentiation in human colon cancer cells. (2005) (11)
- Thyrotropin-releasing hormone modulation of uridine uptake in rat pituitary cells. Characterization of the responses. (1978) (11)
- Familial medullary thyroid carcinoma and pheochromocytoma: epidemiologic investigations. (1974) (11)
- Chemical nature and properties of parathyroid hormones. (1963) (11)
- Pseudohypoparathyroidism: no improvement following total thyroidectomy. (1969) (11)
- Protein kinase A-dependent inhibition of alkaline phosphatase release by SaOS-2 human osteoblastic cells: studies in new mutant cell lines that express a cyclic AMP-resistant phenotype. (1991) (10)
- Stimulation of bone resorption in organ culture by cholera toxin. (1981) (10)
- Immunocytochemical analysis of prolactin production by monolayer cultures of GH3 rat anterior pituitary tumor cells: I. Long‐term effects of stimulation with thyrotropin‐releasing hormone (TRH) (1980) (10)
- Relationships between amplitudes and kinetics of rapid cytosolic free calcium fluctuations in GH4C1 rat pituitary cells: roles for diffusion and calcium-induced calcium release. (1994) (10)
- Forskolin-induced homologous desensitization via an adenosine 3',5'-monophosphate-dependent mechanism(s) in human osteoblast-like SaOS-2 cells. (1992) (10)
- Agranulocytosis associated with phenindione: a case report with review of the literature. (1960) (9)
- Antropyloric G-cell hyperplasia in hypercalcemic rabbits bearing the VX2 carcinoma. (1977) (9)
- Impact of prospective screening for multiple endocrine neoplasia type 2. (1987) (9)
- 12-O-tetradecanoyl-phorbol-13-acetate decreases influx of extracellular Ca2+ induced by depolarization in GH4C1 cells: effects of pretreatment with 1,25-dihydroxycholecalciferol. (1990) (9)
- Diagnostic dependability of calcitonin assay in family studies for medullary thyroid carcinoma. (1971) (9)
- Palytoxin modulates cytosolic pH in human osteoblast-like Saos-2 cells via an interaction with Na(+)-K(+)-ATPase. (1996) (9)
- Solubilization of receptors for thyrotropin-releasing hormone from GH4C1 rat pituitary cells: demonstration of guanyl nucleotide sensitivity. (1987) (9)
- Clinical value of tumor doubling estimations in multiple endocrine neoplasia type II. (1984) (9)
- 17 – Human Calcitonin: Application of Affinity Chromatography (1978) (8)
- Hormonal regulation of cytosolic free calcium and its functional consequences: the GH-cell model. (1990) (8)
- User-friendly and versatile software for analysis of protein hydrophobicity. (1998) (8)
- Cyclic ADP-ribose-induced calcium release in sea urchin egg homogenates is a cooperative process. (1995) (8)
- Distribution of thyroid, parathyroid, and ultimobranchial hypocalcemic factors in birds. II. Morphology, Histochemistry, and hypocalcemic activity of pigeon thyroid glands (1973) (8)
- Stability of the hypocalcemic activity of porcine thyrocalcitonin. (1967) (8)
- Antitumor activity of DL-threo-beta-fluoroasparagine against human leukemia cells in culture and L1210 cells in DBA mice. (1984) (8)
- Evidence for multiple bone resorption-stimulating factors produced by normal human keratinocytes in culture. (1988) (7)
- Control of intracellular calcium redistribution by guanine nucleotides and inositol 1,4,5-trisphosphate in permeabilized GH4C1 cells. (1991) (7)
- Platelet-activating factor affects cytosolic free calcium concentration and prolactin secretion in GH4C1 rat pituitary cells. (1991) (7)
- Unexpectedly high biological activity of synthetic human calcitonin. (1970) (7)
- Distribution of thyroid, parathyroid, and ultimobranchial hypocalcemic factors in birds. 1. Thyroid and ultimobranchial calcitonins in pigeons and pullets. (1972) (7)
- Decreased thyrocalcitonin in thyroid glands from patients with hyperparathyroidism. (1967) (6)
- Rabbit, guinea pig, rat and human antibodies to human growth hormone: immunological reactions with human and nonhuman primate growth hormones. (1966) (6)
- Clonal analysis of a 5-azacytidine-induced specific increase in growth hormone production by rat pituitary cells. (1983) (6)
- Pretreatment with 17β-Estradiol Attenuates Basal- and PTH-Stimulated Membrane Adenylyl Cyclase Activity in Human Osteoblast-like SAOS-2 Cells (1996) (6)
- PARTIAL HYDROLYSIS OF BOVINE PARATHYROID HORMONE BY DILUTE ACID AND PROTEOLYTIC ENZYMES: EFFECTS ON IMMUNOLOGICAL AND BIOLOGICAL ACTIVITIES. (1965) (6)
- The thyrotropin-releasing hormone-receptor complex and G11alpha are both internalised into clathrin-coated vesicles. (1998) (6)
- Kinetics and reversibility of thyrotropin-releasing hormone-stimulated guanine nucleotide exchange in membranes from GH4C1 cells. (1994) (5)
- Pituitary immunoreactive calcitonin-like material: lack of evidence for cross-reactivity with pro-opiomelanocortin. (1983) (5)
- Parathyroid hormone and calcitonin interactions in bone: Irradiation-induced inhibition of escape in vitro (1982) (5)
- Labeled Bilirubin Production by a Clonal Strain of Rat Hepatoma Cells 1 (1971) (5)
- Voltage-dependent Calcium Channels in Pituitary Cells in Culture (2001) (4)
- KINETICS OF HUMAN CITRATE METABOLISM: STUDIES IN NORMAL SUBJECTS AND IN PATIENTS WITH BONE DISEASE. (1963) (4)
- Clinical value of calcitonin and carcinoembryonic antigen doubling times in medullary thyroid carcinoma. (1987) (4)
- Alterations in the frequency and shape of Ca2+ fluctuations in GH4C1 cells induced by thyrotropin-releasing hormone and Bay K 8644. (1995) (4)
- Ca2+ and Extracellular Acidification Rate Responses to Parathyroid Hormone Fragments in Rat ROS 17/2 and Human SaOS-2 Cells (1999) (4)
- Use of minoxidil to demonstrate that prostacyclin is not the mediator of bone resorption stimulated by growth factors in mouse calvariae. (1988) (4)
- Human medullary thyroid carcinoma: control of calcitonin secretion in vivo and in tissue culture. (1974) (4)
- Thyrocalcitonin: partition on carboxymethyl-sephadex C-25 and characterization by disc gel electrophoresis. (1967) (4)
- Letter: Whence the calcitonin. (1973) (3)
- Drug Toxicity. (1964) (3)
- Soft bones, hard facts and calcitonin therapy. (1970) (3)
- Quenching of intrinsic tryptophan fluorescence in membranes of rat pituitary cells. (1979) (3)
- Thyrotropin-releasing hormone increases prolactin mRNA activity in the cytoplasm of GH-cells as measured by translation in a wheat germ cell-free system. (1976) (3)
- Calcium regulating hormones and bone metabolism : basic and clinical aspects, vol. 11 : proceedings of the 11th International Conference on Calcium Regulating Hormones, Florence, 24-29 April 1992 (1992) (2)
- Pyroglutamyl-histidyl-prolineamide (TRH). A neurohormone which affects the release and synthesis of prolactin and thyrotropin. (1974) (2)
- Immunochemistry of thyrocalcitonins species differences and studies of the relationships between structure and immunological activity (1970) (2)
- Studies in familial thyroid cancer. (1971) (2)
- Novel action of pituitary adenylate cyclase-activating polypeptide. Stimulation of extracellular acidification in rat pituitary GH4C1 cells. (2000) (2)
- Inhibition of asparagine-linked glycosylation of pro-opiomelanocortin in mouse pituitary cells by DL-threo-beta-fluoroasparagine. (1983) (2)
- DL-THREO-β-FLUOROASPARTATE AND LD-THREO-β-FLUOROASPARAGINE: SELECTIVE CYTOTOXIC AGENTS FOR MAMMALIAN CELLS IN CULTURE (1982) (2)
- Regulation of pHi in Saos-2 cells by thrombin: roles of proteolytic activity and cytosolic calcium transients. (1992) (2)
- New insights into interactions between the human PTH/PTHrP receptor and agonist/antagonist binding. (1998) (2)
- The syndrome of multiple aucosal neuromas and medullary thyroid carcinoma in childhood. Importance of recognition of the phenotype for the early detection of malignancy. (1975) (2)
- Inhibition of parathyroid hormone-stimulated bone resorption by monovalent cation ionophores (1982) (2)
- Letter: Prostaglandins, bone resorption and hyperglycemia. (1974) (2)
- Inhibition of monoamine oxidase activity by propargylamine in pituitary cells in culture: lack of effect on cell growth or proclactin production☆ (1974) (2)
- Regulation of Prolactin and Growth Hormone Production by Clonal Strains of Functional Pituitary Cells in Culture (1975) (1)
- Control of the production of two protein hormones by rat pituitary cells in culture (1970) (1)
- Inhibition of monoamine oxidase activity by propargylamine in pituitary cells in culture: lack of effect on cell growth or prolactin production. (1974) (1)
- Pretreatment with 17 beta-estradiol attenuates basal- and PTH-stimulated membrane adenylyl cyclase activity in human osteoblast-like SAOS-2 cells. (1996) (1)
- Ca(2+) and extracellular acidification rate responses to parathyroid hormone fragments in rat ROS 17/2 and human SaOS-2 cells. (1999) (1)
- Toward an Understanding of Human Parathyroid Hormone Structure and Function (2005) (1)
- PROLACTIN‐PRODUCING CELLS IN CULTURE: CONTROL OF HORMONE BIOSYNTHESIS AND RELEASE (1977) (1)
- Comparative C19-radiosteroid metabolism by MA 160 and HeLa cell lines (1977) (1)
- Editorial: Prostaglandins, hypercalcemia and cancer. (1975) (1)
- Voltage-dependent Calcium Channels in Pituitary Cells in Culture 11 (2001) (1)
- High-sensitivity serum calcitonin assays applied to screening for thyroid C-cell disease in multiple endocrine neoplasia type 2A. (1992) (1)
- Parathyroid gland. (1963) (1)
- Production and characterization of an antiserum which recognizes the native receptor for thyrotropin-releasing hormone. (2001) (1)
- Natural history of familial medullary carcinoma of the thyroid gland (MCT) pheochromocytoma syndrome and the identification of preneoplastic stages by screening tests. A five year report (1975) (1)
- Case report. Blood-streaked sputum. (1974) (0)
- Evaluation of Thyroid and Parathyroid Functions. Proceedings of the Third Applied Seminar of the Association of Clinical Scientists.F. William Sunderman , F. William Sunderman, Jr. (1965) (0)
- MOLECULAR MODEL OF PTHRP (1-34) IN COMPLEX WITH THE PTH/PTHRP RECEPTOR (PTHR1). (2000) (0)
- Oral abstractIntracellular calcium mobilization: Molecular cloning of the rat lactotroph thyrotropin-releasing hormone receptor and the actions of cyclic ADP-ribose in mammalian cells (1992) (0)
- Time-dependent Changes in Protein Kinase C Distribution and Disappearance in Phorbol Ester-treated Human Osteosarcoma Cells 1 (2006) (0)
- (TRH) Receptor Messenger RNA by TRH in GH&, Cells (1993) (0)
- Studies on the potentiation of the calcium-mobilizing activity of parathyroid hormone by cysteine hydrochloride and gelatin. (1970) (0)
- ACUTE PHASE REACTANTS CERULOPLASMIN AND HAPTOGLOBIN AND THEIR RELATIONSHIP TO PLASMA PROSTAGLANDINS IN RABBITS BEARING THE VX~ CARCINOMA* (2003) (0)
- Synthesis and characterization of a high-affinity photoactivatable analogue of thyrotropin-releasing hormone. (1992) (0)
- MOLECULAR MODEL OF THE CRYSTAL STRUCTURE OF HUMAN PARATHYROID HORMONE 1-34 COMPLEXED WITH PTH/PTHRP RECEPTOR. (2000) (0)
- Effects of L-dopa and bromocriptine on calcitonin secretion in medullary thyroid carcinoma. (1980) (0)
- Introduction to hormones as signals and hormones as products of animal cells in culture (1970) (0)
- Radioimmunoassay for phorbol esters using rabbit antisera against phorbol succinate. (1985) (0)
- Unexpected Resistance toX-Irradiation inaStrain ofHybridMammalianCells (mousefibroblasts/!rat pituitary cells/chromosome number) (1972) (0)
- Mechanisms of bone remodeling induced by tumors: tumor humors. (1981) (0)
- Thyrotropin-releasing Hormone Modulation of Uridine Uptake in Rat Pituitary Cells (2011) (0)
- Radioimmunoassayfor PhorbolEsters UsingRabbitAntiseraagainst Phorbol (2006) (0)
- a and f 3 human transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvaria ( bone resorption / prostaglandin E 2 ) (0)
- Editorial: Tumor humors and the hypercalcemias of cancer. (1974) (0)
- Effects of Endopeptidases, Heat and Oxidizing Agents on the Hypocalcemic Activity of Porcine Thyrocalcitonin1 (1968) (0)
- Antitumor Activity of DL-ffà ̄ reo-0-Fluoroasparagine against Human Leukemia Cells in Culture and L 1210 Cells in DBA Mice 1 (2006) (0)
- New insights into interactions between the human PTH/PTHrP receptor and agonist/antagonist binding. (1998) (0)
- Cells Disappearance in Phorbol Ester-treated Human Osteosarcoma Time-dependent Changes in Protein Kinase C Distribution and Updated Version (2006) (0)
- Time-dependent Changes in Protein Kinase C Distribution and Disappearance in Phorbol Ester-treated Human Osteosarcoma Cells1 (2006) (0)
- The inositol lipid signalling system: generation of multiple intracellular messenger molecules. (1990) (0)
- VIP and bone: Evidence for neural control of bone resorption (1985) (0)
- Oral antibiotics and serum cholesterol level in man. (1963) (0)
- Multiple differentiated functions in an unusual clonal strain of hepatoma cells (1970) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Armen H. Jr. Tashjian?
Armen H. Jr. Tashjian is affiliated with the following schools: